These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 12115196

  • 1. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment.
    Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS.
    Arthritis Rheum; 2002 Jun; 46(6):1634-42. PubMed ID: 12115196
    [Abstract] [Full Text] [Related]

  • 2. Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance.
    Keenan NG, Mason JC, Maceira A, Assomull R, O'Hanlon R, Chan C, Roughton M, Andrews J, Gatehouse PD, Firmin DN, Pennell DJ.
    Arthritis Rheum; 2009 Nov; 60(11):3501-9. PubMed ID: 19877040
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging.
    Jiang L, Li D, Yan F, Dai X, Li Y, Ma L.
    Int J Cardiol; 2012 Mar 08; 155(2):262-7. PubMed ID: 21059475
    [Abstract] [Full Text] [Related]

  • 4. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis.
    Narváez J, Narváez JA, Nolla JM, Sirvent E, Reina D, Valverde J.
    Rheumatology (Oxford); 2005 Apr 08; 44(4):479-83. PubMed ID: 15716321
    [Abstract] [Full Text] [Related]

  • 5. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients.
    Maksimowicz-McKinnon K, Clark TM, Hoffman GS.
    Arthritis Rheum; 2007 Mar 08; 56(3):1000-9. PubMed ID: 17328078
    [Abstract] [Full Text] [Related]

  • 6. Takayasu's arteritis: assessment of disease activity with contrast-enhanced MR imaging.
    Choe YH, Han BK, Koh EM, Kim DK, Do YS, Lee WR.
    AJR Am J Roentgenol; 2000 Aug 08; 175(2):505-11. PubMed ID: 10915704
    [Abstract] [Full Text] [Related]

  • 7. Takayasu arteritis in Thailand: clinical and imaging features.
    Suwanwela N, Piyachon C.
    Int J Cardiol; 1996 Aug 08; 54 Suppl():S117-34. PubMed ID: 9119513
    [Abstract] [Full Text] [Related]

  • 8. Vessel Wall Inflammation of Takayasu Arteritis Detected by Contrast-Enhanced Magnetic Resonance Imaging: Association with Disease Distribution and Activity.
    Kato Y, Terashima M, Ohigashi H, Tezuka D, Ashikaga T, Hirao K, Isobe M.
    PLoS One; 2015 Aug 08; 10(12):e0145855. PubMed ID: 26720837
    [Abstract] [Full Text] [Related]

  • 9. Role of magnetic resonance imaging in the early diagnosis of Takayasu arteritis.
    Halefoglu AM, Yakut S.
    Australas Radiol; 2005 Oct 08; 49(5):377-81. PubMed ID: 16174175
    [Abstract] [Full Text] [Related]

  • 10. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY, Kostanian V, Rivera M, Lee KW, Chen CC, Nguyen TH.
    Cardiovasc Intervent Radiol; 2007 Oct 08; 30(4):675-87. PubMed ID: 17573553
    [Abstract] [Full Text] [Related]

  • 11. Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity.
    Papa M, De Cobelli F, Baldissera E, Dagna L, Schiani E, Sabbadini M, Del Maschio A.
    AJR Am J Roentgenol; 2012 Mar 08; 198(3):W279-84. PubMed ID: 22358026
    [Abstract] [Full Text] [Related]

  • 12. Detecting disease extent and activity of Takayasu arteritis using whole-body magnetic resonance angiography and vessel wall imaging as a 1-stop solution.
    Li D, Lin J, Yan F.
    J Comput Assist Tomogr; 2011 Mar 08; 35(4):468-74. PubMed ID: 21765303
    [Abstract] [Full Text] [Related]

  • 13. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
    de Souza AW, da Silva MD, Machado LS, Oliveira AC, Pinheiro FA, Sato EI.
    Scand J Rheumatol; 2012 May 08; 41(3):227-30. PubMed ID: 22400913
    [Abstract] [Full Text] [Related]

  • 14. Takayasu arteritis: evaluation with MR imaging.
    Yamada I, Numano F, Suzuki S.
    Radiology; 1993 Jul 08; 188(1):89-94. PubMed ID: 8099751
    [Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinases as novel disease markers in Takayasu arteritis.
    Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, Nakamura T, Yamashita S, Matsuzawa Y.
    Circulation; 2003 Sep 23; 108(12):1469-73. PubMed ID: 12952836
    [Abstract] [Full Text] [Related]

  • 16. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis.
    Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N.
    J Rheumatol; 2003 Aug 23; 30(8):1793-8. PubMed ID: 12913937
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
    Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P.
    Arthritis Rheum; 2004 Jul 23; 50(7):2296-304. PubMed ID: 15248230
    [Abstract] [Full Text] [Related]

  • 18. Value of whole-body contrast-enhanced magnetic resonance angiography with vessel wall imaging in quantitative assessment of disease activity and follow-up examination in Takayasu's arteritis.
    Sun Y, Ma L, Ji Z, Zhang Z, Chen H, Liu H, Shan Y, Yan F, Jiang L.
    Clin Rheumatol; 2016 Mar 23; 35(3):685-93. PubMed ID: 25665823
    [Abstract] [Full Text] [Related]

  • 19. Absence of Mycobacterium tuberculosis in arterial lesions from patients with Takayasu's arteritis.
    Arnaud L, Cambau E, Brocheriou I, Koskas F, Kieffer E, Piette JC, Amoura Z.
    J Rheumatol; 2009 Aug 23; 36(8):1682-5. PubMed ID: 19531763
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.